Mukka Proteins Q1 2026 Earnings Skyrocket: Revenue Up 200%

Mukka Proteins delivered a robust financial performance for the June 2026 quarter, reporting a substantial 1609.96% increase in net profit year-over-year. This significant growth was underpinned by a near 200% surge in total revenue, signaling strong operational momentum.

Key Financial Highlights (June 2026 Quarter)

• Total Revenue: Rs 4058.56 million, marking a 198.88% increase from Rs 1357.92 million in June 2025.
• Net Profit: Rs 194.08 million, up from Rs 11.35 million in the prior year’s comparable quarter.
• Operating Profit (PBIDT): Rs 441.35 million, demonstrating a 226.85% rise compared to Rs 135.03 million in June 2025.

The company’s substantial revenue growth points to strong market demand and effective sales strategies during the period. This top-line expansion directly translated into enhanced profitability, highlighting improved operational efficiencies.

Operational Metrics Breakdown

• Other Income: Declined by 19.13% to Rs 22.99 million from Rs 28.43 million.
• Interest Expenses: Rose 41.71% to Rs 146.67 million, up from Rs 103.50 million.
• Profit Before Depreciation and Tax (PBDT): Soared 834.60% to Rs 294.68 million, compared to Rs 31.53 million in June 2025.
• Depreciation: Increased by 45.21% to Rs 19.69 million, up from Rs 13.56 million.
• Profit Before Tax (PBT): Stood at Rs 274.99 million for the quarter.

Mukka Proteins’ June 2026 quarter results clearly indicate a period of aggressive expansion and strong financial leverage. The significant increases across key profitability metrics suggest that the company is effectively capitalizing on its growth opportunities, positioning itself for continued momentum.